Pulmonary hypertension (PH) is recognized to be associated with a number of comorbid
conditions. Based on these associations, PH is classified into 5 groups, considering …

Pulmonary hypertension (PH) has historically been categorized into 5 groups based on
similar pathophysiological mechanisms, hemodynamic characteristics, and therapeutic …

Ever since the second world symposium on pulmonary hypertension (PH) held in Evian,
France, in 1998, PH has been classified into five major clinical groups. Group 5 PH includes …

In the over 100 years since the recognition of pulmonary hypertension (PH), immense
progress and significant achievements have been made with regard to understanding the …

The World Health Organization (WHO) group 3 pulmonary hypertension (PH) is considered
the ultimate sequelae of chronic respiratory disease or chronic hypoxia. Compared with …

As can be seen by the mounting literature, there has been immense progress in the field of
pulmonary hypertension (PH) over the last three decades, illustrated by several important …

Pulmonary hypertension (PH) because of chronic lung disease is categorized as Group 3
PH in the most recent classification system. Prevalence of these diseases is increasing over …

Pulmonary hypertension (PH) with unclear multifactorial mechanisms or group 5 PH is an
important category in the Dana Point classification scheme (Box 1). 1 Although often …

Abstract In 2013, the Fifth World Symposium on Pulmonary Hypertension (PH) was held in
Nice, France. This meeting has been held every 5 years since the Second World …

This article reviews selected studies published in 2009 covering advances in the pulmonary
hypertension field. Material covered includes the recent changes in the classification of …